Breast cancers cancers cdk6. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Axilla Mammary Glands, Human Neoplastic Stem Cells Lymph Nodes Nipples Epithelial Cells Neoplastic Cells, Circulating Cell Line

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases47

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Metastasis Neoplasm Invasiveness Breast Diseases Ovarian Neoplasms Breast Neoplasms, Male Genetic Predisposition to Disease Lung Neoplasms Prostatic Neoplasms Carcinoma Carcinoma, Lobular Neoplasms Neoplasm Recurrence, Local Carcinoma, Intraductal, Noninfiltrating Colonic Neoplasms Neoplasms, Hormone-Dependent Disease Progression Stomach Neoplasms Mammary Neoplasms, Experimental Pancreatic Neoplasms Lymphatic Metastasis Cell Transformation, Neoplastic Bone Neoplasms Fibrocystic Breast Disease Uterine Cervical Neoplasms Neoplasms, Second Primary Colorectal Neoplasms Adenocarcinoma Carcinoma in Situ Carcinoma, Squamous Cell Carcinoma, Ductal Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Endometrial Neoplasms Neovascularization, Pathologic Triple Negative Breast Neoplasms Neoplasms, Radiation-Induced Inflammatory Breast Neoplasms Rectal Neoplasms Neoplastic Cells, Circulating Neoplasms, Multiple Primary Liver Neoplasms Fibroadenoma Esophageal Neoplasms Precancerous Conditions Neoplasms, Basal Cell

Chemicals and Drugs65

Receptors, Estrogen Receptor, erbB-2 Tamoxifen Receptors, Progesterone Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents Antineoplastic Agents, Hormonal RNA, Messenger Estrogens Estrogen Receptor alpha BRCA2 Protein Cyclin-Dependent Kinases BRCA1 Protein DNA, Neoplasm RNA, Small Interfering Cancer Vaccines Estrogen Antagonists Aromatase Inhibitors Fluorouracil Tumor Suppressor Protein p53 Tumor Suppressor Proteins Cyclin-Dependent Kinase 2 Antibodies, Monoclonal, Humanized Estradiol Cyclin-Dependent Kinase 4 Antibodies, Monoclonal Estrogen Receptor Modulators Paclitaxel Antigens, Neoplasm Receptor, Epidermal Growth Factor Cyclophosphamide Cyclin-Dependent Kinase 5 Protein-Serine-Threonine Kinases Anticarcinogenic Agents Nitriles Epirubicin RNA, Neoplasm Selective Estrogen Receptor Modulators Transcription Factors Cell Cycle Proteins Proto-Oncogene Proteins Ki-67 Antigen DNA-Binding Proteins Cyclin D1 MicroRNAs Nuclear Proteins Cisplatin Antineoplastic Agents, Phytogenic Prostate-Specific Antigen Mucin-1 Antibiotics, Antineoplastic Antigens, CD24 Cyclins Proto-Oncogene Proteins c-akt CDC2-CDC28 Kinases Deoxycytidine Triazoles Anthracyclines Protein Kinase Inhibitors Enzyme Inhibitors Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinase 6 Antimetabolites, Antineoplastic Cyclin-Dependent Kinase Inhibitor p21

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Early Detection of Cancer Mammography Prognosis Neoplasm Staging Risk Factors Chemotherapy, Adjuvant Mastectomy Survival Analysis Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Risk Survival Rate Follow-Up Studies Disease-Free Survival Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Retrospective Studies Mammary Neoplasms, Experimental Risk Assessment Odds Ratio Immunohistochemistry Breast Self-Examination Xenograft Model Antitumor Assays Blotting, Western Registries Case-Control Studies Incidence Neoplasm Transplantation Multivariate Analysis Treatment Outcome Transplantation, Heterologous Sensitivity and Specificity Mastectomy, Segmental Oligonucleotide Array Sequence Analysis Combined Modality Therapy Kaplan-Meier Estimate SEER Program Questionnaires Cohort Studies Tumor Burden Transfection Predictive Value of Tests Logistic Models Tissue Array Analysis Polymerase Chain Reaction Reproducibility of Results Neoplasm Grading Clinical Trials as Topic Drug Screening Assays, Antitumor Confidence Intervals Ultrasonography, Mammary Immunoenzyme Techniques Molecular Targeted Therapy Radiotherapy, Adjuvant Radiotherapy Gene Knockdown Techniques Genetic Testing Drug Administration Schedule Models, Biological Biopsy Breast Implants Lymph Node Excision Biopsy, Needle Mammaplasty In Situ Hybridization, Fluorescence DNA Mutational Analysis Estrogen Replacement Therapy Sentinel Lymph Node Biopsy Flow Cytometry Mass Screening

Psychiatry and Psychology3

Breast Self-Examination Breast Feeding Smoking

Phenomena and Processes49

Gene Expression Regulation, Neoplastic Genes, BRCA1 Genetic Predisposition to Disease Drug Resistance, Neoplasm Postmenopause Risk Cell Proliferation Premenopause Mutation Odds Ratio Breast Feeding Menopause Genes, BRCA2 Cell Cycle Apoptosis Cell Division Genes, erbB-2 Signal Transduction Cell Movement Sensitivity and Specificity Down-Regulation Genotype Phosphorylation DNA Methylation Time Factors Germ-Line Mutation Transfection Promoter Regions, Genetic Polymorphism, Genetic Cell Growth Processes RNA Interference Dose-Response Relationship, Drug Cell Survival Up-Regulation Gene Amplification Gene Silencing Gene Expression Genes, Tumor Suppressor Base Sequence Phenotype Genes, Neoplasm Genes, p53 Parity Epithelial-Mesenchymal Transition Alleles Diet Transcription, Genetic Drug Synergism Heterozygote

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence SEER Program Questionnaires Molecular Sequence Data Base Sequence

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care31

Risk Factors Survival Analysis Risk Survival Rate Follow-Up Studies Disease-Free Survival Prospective Studies Retrospective Studies Risk Assessment Age Factors Odds Ratio Registries Case-Control Studies Incidence Multivariate Analysis Treatment Outcome Sensitivity and Specificity Kaplan-Meier Estimate SEER Program Questionnaires Cohort Studies Predictive Value of Tests Logistic Models National Cancer Institute (U.S.)Reproducibility of Results Clinical Trials as Topic Confidence Intervals Genetic Testing Parity American Cancer Society Mass Screening

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Breast Neoplasms Receptors, Estrogen Carcinoma, Ductal, Breast Cell Line, Tumor Receptor, erbB-2 Early Detection of Cancer Gene Expression Regulation, Neoplastic Tamoxifen Neoplasm Metastasis Neoplasm Invasiveness Breast Diseases Receptors, Progesterone Mammography Prognosis Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents Neoplasm Staging Antineoplastic Agents, Hormonal Ovarian Neoplasms Mice, Nude Breast Neoplasms, Male Genes, BRCA1 Risk Factors Chemotherapy, Adjuvant Genetic Predisposition to Disease Mastectomy Lung Neoplasms Prostatic Neoplasms Survival Analysis Drug Resistance, Neoplasm Antineoplastic Combined Chemotherapy Protocols Postmenopause Carcinoma Carcinoma, Lobular Gene Expression Profiling Risk Tumor Cells, Cultured Neoplasms Survival Rate Follow-Up Studies MCF-7 Cells Disease-Free Survival Reverse Transcriptase Polymerase Chain Reaction Cell Proliferation Neoplasm Recurrence, Local Carcinoma, Intraductal, Noninfiltrating Colonic Neoplasms RNA, Messenger Neoplasms, Hormone-Dependent Prospective Studies Estrogens Estrogen Receptor alpha Disease Progression Premenopause Stomach Neoplasms Retrospective Studies Mammary Neoplasms, Experimental Risk Assessment Survivors Mutation Age Factors Odds Ratio BRCA2 Protein Cyclin-Dependent Kinases Immunohistochemistry Breast Self-Examination Xenograft Model Antitumor Assays Blotting, Western Breast Feeding Menopause Genes, BRCA2 Cell Cycle BRCA1 Protein DNA, Neoplasm RNA, Small Interfering Registries Case-Control Studies Apoptosis United States Pancreatic Neoplasms Cancer Vaccines Cell Division Estrogen Antagonists Aromatase Inhibitors Incidence Fluorouracil Neoplasm Transplantation Lymphatic Metastasis Multivariate Analysis Genes, erbB-2 Signal Transduction Treatment Outcome Tumor Suppressor Protein p53 Cell Movement Transplantation, Heterologous Sensitivity and Specificity Cell Transformation, Neoplastic Mastectomy, Segmental

No FAQ available that match "breast cancers cancers cdk6"